$6
Journey Medical Corporation is a drug manufacturers - specialty & generic business based in the US. Journey Medical Corporation shares (DERM) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $6.12 – an increase of 4.97% over the previous week. Journey Medical Corporation employs 41 staff and has a trailing 12-month revenue of around $77.7 million.
What's in this guide?
- DERM shares summary
- Compare share dealing platforms
- Is DERM stock a buy or sell?
- Stock performance over time
- Can I short DERM shares?
- Are DERM shares over-valued?
- Journey Medical Corporation's financials
- How volatile are DERM shares?
- Does Journey Medical Corporation pay a dividend?
- Other common questions
Our top picks for where to buy Journey Medical stock
- Earn 4.5% interest on uninvested cash with Gold
- Get up to $50,000 in instant deposits with Gold
- Easy, user-friendly trading
- Unlimited bonus amounts Oct 16-27
- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options, with no options contract fees
- Complimentary access to a financial planner and automated investing
How to buy Journey Medical Corporation stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – DERM. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Journey Medical Corporation stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Journey Medical Corporation stock price (NASDAQ: DERM)
Use our graph to track the performance of DERM stocks over time.Journey Medical Corporation shares at a glance
Latest market close | $6.12 |
---|---|
52-week range | $2.85 - $8.11 |
50-day moving average | $5.17 |
200-day moving average | $4.64 |
Wall St. target price | $9.13 |
PE ratio | 44.9231 |
Dividend yield | N/A |
Earnings per share (TTM) | $0.13 |
Is it a good time to buy Journey Medical Corporation stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Journey Medical Corporation price performance over time
Historical closes compared with the close of $6.12 from 2024-10-18
1 week (2024-10-11) | 4.97% |
---|---|
1 month (2024-09-20) | 21.19% |
3 months (2024-07-19) | 12.09% |
6 months (2024-04-19) | 75.86% |
1 year (2023-10-20) | 88.31% |
---|---|
2 years (2022-10-20) | 141.42% |
3 years (2021-10-16) | N/A |
5 years (2019-10-16) | N/A |
Is Journey Medical Corporation stock undervalued or overvalued?
Valuing Journey Medical Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Journey Medical Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Journey Medical Corporation's P/E ratio
Journey Medical Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 45x. In other words, Journey Medical Corporation shares trade at around 45x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
However, Journey Medical Corporation's P/E ratio is best considered in relation to those of others within the drug manufacturers - specialty & generic industry or those of similar companies.
- Anika Therapeutics (ANIK.US): 0.00
- GlaxoSmithKline PLC ADR (GSK.US): 13.16
- STRATA Skin Sciences (SSKN.US): 0.00
Journey Medical Corporation's EBITDA
Journey Medical Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $5.4 million.
The EBITDA is a measure of a Journey Medical Corporation's overall financial performance and is widely used to measure a its profitability.
To put Journey Medical Corporation's EBITDA into context you can compare it against that of similar companies.
- Anika Therapeutics (ANIK.US): USD$11.3 million
- GlaxoSmithKline PLC ADR (GSK.US): USD$11 billion
- STRATA Skin Sciences (SSKN.US): USD$80000
Journey Medical Corporation financials
Revenue TTM | $77.7 million |
---|---|
Gross profit TTM | $42.9 million |
Return on assets TTM | 1.97% |
Return on equity TTM | 14.92% |
Profit margin | 1.09% |
Book value | $0.56 |
Market Capitalization | $121 million |
TTM: trailing 12 months
Journey Medical Corporation share price volatility
Over the last 12 months, Journey Medical Corporation's shares have ranged in value from as little as $2.85 up to $8.11. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Journey Medical Corporation's is 0.929. This would suggest that Journey Medical Corporation's shares are less volatile than average (for this exchange).
To put Journey Medical Corporation's beta into context you can compare it against those of similar companies.
- Anika Therapeutics (ANIK.US): 0.833
- GlaxoSmithKline PLC ADR (GSK.US): 0.309
- STRATA Skin Sciences (SSKN.US): 1.359
Journey Medical Corporation overview
Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris. It also offers Zilxi, a topical minocycline treatment for inflammatory lesions of rosacea; Exelderm cream and solution an antifungal intended for topical use; Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; and Luxamend, a water-based emulsion formulated to provide a moist healing environment for superficial wounds; minor cuts or scrapes; dermal ulcers; donor sites; first- and second-degree burns, including sunburns; and radiation dermatitis. In addition, the company sells sulconazole nitrate cream and solution indicated for the treatment of tinea cruris, tinea corporis, and tinea versicolor; and doxycycline hyclate tablets, as an adjunctive therapy for severe acne. The company was formerly known as Coronado Dermatology, Inc. and changed its name to Journey Medical Corporation. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.
Frequently asked questions
What percentage of Journey Medical Corporation is owned by insiders or institutions?Currently 30.813% of Journey Medical Corporation shares are held by insiders and 16.062% by institutions. How many people work for Journey Medical Corporation?
Latest data suggests 41 work at Journey Medical Corporation. When does the fiscal year end for Journey Medical Corporation?
Journey Medical Corporation's fiscal year ends in December. Where is Journey Medical Corporation based?
Journey Medical Corporation's address is: 9237 East Via de Ventura Boulevard, Scottsdale, AZ, United States, 85258 What is Journey Medical Corporation's ISIN number?
Journey Medical Corporation's international securities identification number is: US48115J1097
More guides on Finder
-
Fundamental Analysis
Fundamental analysis of stocks can help you become a better investor and find the true value of stocks and other assets.
-
Best Stocks for Beginners With Little Money to Invest
These are the stocks to buy when you don’t have much to spend.
-
Best broker cash sweep rates of 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 Best Day Trading Apps of 2024
These are the best day trading apps, according to Finder’s comprehensive analysis.
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
Titan Review 2024: Wealth Management With a No-Advisory-Fee Robo-Advisor
Titan invest is a members-only automated platform best for hands-off investors looking to build wealth.
-
Public.com Review 2024: No-Fee Options, With Rebates
A beginner-friendly investing platform with fractional shares and no commissions on stocks and ETFs.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
Wealthfront review: Low-cost automated and DIY investing
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.
-
How to trade options
Read our beginner’s guide to trading options in the US.
Ask a question